Supernus Pharmaceuticals, Inc. (SUPN)
NASDAQ: SUPN · IEX Real-Time Price · USD
30.25
+1.15 (3.95%)
At close: Jul 19, 2024, 4:00 PM
30.29
+0.04 (0.13%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

Supernus Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year Ending
TTM Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019 2018 - 2009
Revenue
597.4607.52667.24579.78520.4392.76
Upgrade
Revenue Growth (YoY)
-10.64%-8.95%15.09%11.41%32.50%-3.95%
Upgrade
Cost of Revenue
76.6383.7887.2275.0652.4616.66
Upgrade
Gross Profit
520.77523.74580.02504.71467.94376.1
Upgrade
Selling, General & Admin
337.28336.36377.22304.76200.68153.25
Upgrade
Research & Development
95.3191.5974.5590.4775.9669.1
Upgrade
Other Operating Expenses
104.39102.5782.6329.9917.65.18
Upgrade
Operating Expenses
536.98530.53534.4425.22294.24227.52
Upgrade
Operating Income
-16.21-6.7945.6179.5173.7148.57
Upgrade
Interest Expense / Income
0.912.427.0723.4223.7522.71
Upgrade
Other Expense / Income
-11.12-11.97-22.2-17.1-18.7-21.62
Upgrade
Pretax Income
-6.012.7760.7473.18168.65147.49
Upgrade
Income Tax
9.51.450.0319.7541.734.43
Upgrade
Net Income
-15.511.3260.7153.42126.95113.06
Upgrade
Net Income Growth
--97.83%13.64%-57.92%12.29%1.86%
Upgrade
Shares Outstanding (Basic)
555554535352
Upgrade
Shares Outstanding (Diluted)
565662545454
Upgrade
Shares Change
-10.93%-10.01%13.47%1.24%-0.24%-0.52%
Upgrade
EPS (Basic)
-0.290.021.131.012.412.16
Upgrade
EPS (Diluted)
-0.290.021.040.982.362.10
Upgrade
EPS Growth
--98.08%6.12%-58.47%12.38%2.44%
Upgrade
Free Cash Flow
99.84110.53116.41125.08134.71141.74
Upgrade
Free Cash Flow Per Share
1.822.032.172.362.562.70
Upgrade
Gross Margin
87.17%86.21%86.93%87.05%89.92%95.76%
Upgrade
Operating Margin
-2.71%-1.12%6.84%13.71%33.38%37.83%
Upgrade
Profit Margin
-2.60%0.22%9.10%9.21%24.39%28.79%
Upgrade
Free Cash Flow Margin
16.71%18.19%17.45%21.57%25.89%36.09%
Upgrade
Effective Tax Rate
-52.47%0.05%26.99%24.72%23.35%
Upgrade
EBITDA
79.9190.04153.36129.19210.54176.85
Upgrade
EBITDA Margin
13.38%14.82%22.98%22.28%40.46%45.03%
Upgrade
Depreciation & Amortization
85.0184.8685.5432.618.146.66
Upgrade
EBIT
-5.15.1867.8196.6192.4170.19
Upgrade
EBIT Margin
-0.85%0.85%10.16%16.66%36.97%43.33%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).